Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesComparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer
European Journal of Cancer, 10/20/09
Dauplata J et al. – Findings of this study support a possible relationship between OED and the use of ovulation-stimulating drugs. The increased dysplasia score in stimulated and genetic risk ovaries might be consistent with progression towards neoplastic transformation, and may justify the use of the term dysplasia or intraepithelial ovarian neoplasia. The observation of dysplasia in the stimulated group may differentiate women at risk. Conversely, the fact that the dysplasia profile after stimulation differs from that in genetic risk ovaries suggests that ovarian stimulation may predispose to a different evolution.
Methods- 124 patients who had undergone salpingo-oophorectomies or ovarian cystectomies between 1990 and 2005 reviewed
- Divided into 3 groups: (1) previous in vitro fertilisation (n=35); (2) prophylactic oophorectomies for genetic risk (n=27) and (3) fertile non-cancerous controls (n=62)
- 11 cytological and architectural epithelial features defined and dysplasia score calculated to quantify ovarian epithelial abnormalities
- Mean dysplasia score significantly higher in genetic risk and stimulated ovary groups than controls
- Cytological and architectural abnormalities more frequent in genetic risk group, while profile of abnormalities different in genetic risk and stimulated groups
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells
Cancer Science, 12/03/09
The effect of endostatin mediated by human mesenchymal stem cells on ovarian cancer cells in vitro
Journal of Cancer Research & Clinical Oncology, 12/03/09
Expression of cyclin D1 and retinoblastoma protein in Pagets disease of the vulva and breast: an immunohistochemical study of 108 cases
Histopathology, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor